NCT06519292View on ClinicalTrials.gov

Immune Checkpoint Inhibitor Associated Cardiovascular Adverse Events in Patients With Cancer

RecruitingOBSERVATIONAL
Enrollment

214

Participants

Timeline

Start Date

January 25, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Cardiovascular DiseasesArterial ThrombosisMyocardial InfarctionStrokeCoronary Artery DiseaseAtherosclerosisCancer
Interventions
DIAGNOSTIC_TEST

Coronary computed tomography angiography (CCTA) at baseline

Detailed imaging of coronary arteries

DIAGNOSTIC_TEST

Coronary computed tomography angiography (CCTA) after 1 year

Detailed imaging of coronary arteries

Trial Locations (1)

1105AZ

RECRUITING

Amsterdam UMC, Amsterdam

All Listed Sponsors
collaborator

Amsterdam UMC

OTHER

lead

Hanneke W. M. van Laarhoven

OTHER